
|Articles|March 9, 2009
Podcasts-WOTY:The Spokesperson Speaks
Advertisement
For nearly 40 years, Carolyn Glynn has risen through the ranks in Roche’s public affairs department. Even more difficult than representing the company to the outside world, she says, was championing outside constituents inside the company to give them a voice.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
3
The Evolving Relationship Between FDA and Biotech
4
What Kinds of Disruption are GLP-1s Expected to Face
5




